Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 1849.06% is 1716% above its 5-year average of -114.41%, near the high end of its 5-year range (-413.34%–1849.06%).
941.70% above its 12-month average of -219.68%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -210.14%.
RETURN ON EQUITY (ROE)
1849.06%
RETURN ON EQUITY (ROE) AVG TTM
-219.68%
RETURN ON EQUITY (ROE) AVG 3Y
-187.92%
RETURN ON EQUITY (ROE) AVG 5Y
-114.41%
RETURN ON EQUITY (ROE) AVG 10Y
-21.95%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+941.70%
CURRENT VS 3Y AVG
+1083.97%
CURRENT VS 5Y AVG
+1716.14%
CURRENT VS 10Y AVG
+8522.41%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.44%
median of 512 covered companies
CURRENT VS SECTOR MEDIAN
+4788.88%
vs the sector median at left
AnaptysBio, Inc.
Market Cap
$1.41B
Return on Equity (ROE)
1849.06%
TTM Avg
-219.68%
3Y Avg
-187.92%
5Y Avg
-114.41%
Market Cap
$1.39B
Return on Equity (ROE)
N/A
TTM Avg
-244.46%
3Y Avg
-323.47%
5Y Avg
-258.47%
Market Cap
$1.45B
Return on Equity (ROE)
-29.48%
TTM Avg
-5.20%
3Y Avg
-280.62%
5Y Avg
-280.62%
Market Cap
$1.43B
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.46B
Return on Equity (ROE)
23.70%
TTM Avg
9.74%
3Y Avg
8.98%
5Y Avg
11.20%
Market Cap
$1.36B
Return on Equity (ROE)
N/A
TTM Avg
41.79%
3Y Avg
41.79%
5Y Avg
41.79%
Market Cap
$1.48B
Return on Equity (ROE)
-17.32%
TTM Avg
-19.51%
3Y Avg
-16.07%
5Y Avg
-12.58%
Market Cap
$557.04M
Return on Equity (ROE)
-44.63%
TTM Avg
-42.69%
3Y Avg
-38.09%
5Y Avg
-55.51%
Market Cap
$1.49B
Return on Equity (ROE)
27.24%
TTM Avg
-16.62%
3Y Avg
-27.07%
5Y Avg
-49.65%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AnaptysBio, Inc. (ANAB) | $1.41B | 1849.06% | -219.68% | -187.92% | -114.41% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | N/A | -244.46% | -323.47% | -258.47% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.45B | -29.48% | -5.20% | -280.62% | -280.62% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 23.70% | 9.74% | 8.98% | 11.20% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.36B | N/A | 41.79% | 41.79% | 41.79% |
| GH Research PLC (GHRS)vs › | $1.48B | -17.32% | -19.51% | -16.07% | -12.58% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $557.04M | -44.63% | -42.69% | -38.09% | -55.51% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.49B | 27.24% | -16.62% | -27.07% | -49.65% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.32B | N/A | 36.18% | 36.18% | 36.18% |
ROE
1849.1%
ROA
61.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -210.14% |
| 2025-12-31 | -35.56% |
| 2025-03-31 | -413.34% |
| 2024-12-31 | -204.93% |
| 2024-09-30 | -196.35% |
| 2024-03-31 | -341.79% |
| 2023-12-31 | -185.71% |
| 2023-09-30 | -122.79% |
| 2023-06-30 | -97.01% |
| 2023-03-31 | -71.55% |
| 2022-12-31 | -49.11% |
| 2022-09-30 | -48.57% |
| 2022-06-30 | -35.49% |
| 2022-03-31 | -22.94% |
| 2021-12-31 | -16.22% |
| 2021-09-30 | 2.19% |
| 2021-06-30 | -2.26% |
| 2021-03-31 | -7.81% |
| 2020-12-31 | -5.02% |
| 2020-09-30 | -20.50% |
| 2020-06-30 | -21.26% |
| 2020-03-31 | -20.85% |
| 2019-12-31 | -24.03% |
| 2019-09-30 | -22.35% |
| 2019-06-30 | -17.62% |
| 2019-03-31 | -14.66% |
| 2018-12-31 | -12.68% |
| 2018-09-30 | -10.31% |
| 2018-06-30 | -15.67% |
| 2018-03-31 | -11.45% |
| 2017-12-31 | -9.78% |
| 2017-09-30 | -27.10% |
| 2017-06-30 | -16.83% |
| 2017-03-31 | -12.14% |
| 2016-12-31 | -7.19% |
| 2016-09-30 | -4.64% |
| 2016-06-30 | -7.97% |
| 2016-03-31 | -14.16% |
| 2015-12-31 | -12.77% |
| 2015-09-30 | -3.05% |
| 2015-06-30 | 60.29% |
| 2015-03-31 | 63.10% |
| 2014-12-31 | 58.94% |
